Related Experiment Video
Updated: Jun 25, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Research progress on function and mechanism of long non-coding RNA in glioma
1First Clinical Medical College, Shanxi Medical University, Taiyuan, China. taifeipeng@163.com.
Abstract:
This review aimed to comprehensively summarize the role of long non-coding RNA (lncRNA) in gliomas, the most common malignant tumors in the central nervous system, and explore their potential clinical applications. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search using the PubMed database was conducted forty studies met the inclusion and exclusion criteria and were analyzed for type of intervention, the study's design, participants' demographics, and outcomes, including attrition. Gliomas, originating within the central nervous system, account for 40-45% of intracranial tumors. Despite advances in neurosurgical techniques, precise radiotherapy, and chemotherapy, the prognosis for glioma patients remains suboptimal. The review highlights the crucial regulatory role of lncRNA in gliomas. Differential expression of various lncRNAs, such as INHEG, SATB2-AS1, PSMB8-AS1, LINC01018, and SPRY4-IT1, has been observed in gliomas, suggesting their involvement in promoting or inhibiting tumorigenesis. Additionally, lncRNAs play roles in glioma characteristics such as proliferation, invasion, migration, angiogenesis, and the presence of glioma stem cells. The potential clinical applications of lncRNA in gliomas involve their association with tumor grading, diameter, metastasis, and family history. This review emphasizes the importance of understanding the molecular mechanisms involving lncRNA in gliomas. The identification of specific lncRNAs associated with gliomas provides potential molecular markers for diagnosis, differentiation, treatment, and prognosis evaluation. Further research is needed to uncover additional key lncRNAs and their underlying mechanisms, ultimately contributing to the improvement of glioma diagnosis and treatment.
Insights
Long non-coding RNAs (lncRNAs) are crucial regulators in gliomas, the most common brain tumors. Understanding lncRNA mechanisms offers new diagnostic and therapeutic strategies for glioma patients.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genomics
Background:
- Gliomas represent the most frequent primary central nervous system tumors, with current treatments offering limited patient prognosis.
- Despite therapeutic advancements, glioma patient outcomes remain suboptimal, necessitating novel diagnostic and therapeutic targets.
Purpose of the Study:
- To systematically review and summarize the role of long non-coding RNAs (lncRNAs) in glioma development and progression.
- To explore the potential clinical applications of lncRNAs as biomarkers for glioma diagnosis, grading, and treatment.
Main Methods:
- A systematic literature search was conducted on the PubMed database, adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Forty studies meeting predefined inclusion and exclusion criteria were analyzed for study design, participant demographics, and outcomes.
Main Results:
- lncRNAs play a critical regulatory role in gliomas, influencing tumorigenesis, proliferation, invasion, migration, and angiogenesis.
- Specific lncRNAs, including INHEG, SATB2-AS1, PSMB8-AS1, LINC01018, and SPRY4-IT1, are differentially expressed in gliomas.
- lncRNA expression correlates with glioma grading, tumor diameter, metastasis, and patient family history.
Conclusions:
- lncRNAs are integral to glioma biology and represent promising molecular markers for early diagnosis, prognosis assessment, and targeted therapy.
- Further research into lncRNA mechanisms is essential for improving glioma patient outcomes and developing novel clinical strategies.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
Experimental RNAi
Non-LTR Retrotransposons
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...